• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Journal of Advanced Pharmacy Research
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 9 (2025)
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 8 (2024)
Volume Volume 7 (2023)
Volume Volume 6 (2022)
Volume Volume 5 (2021)
Volume Volume 4 (2020)
Volume Volume 3 (2019)
Volume Volume 2 (2018)
Volume Volume 1 (2017)
Bariweni, M., Eradiri, Y., Ezeugo, C. (2025). Coenzyme-Q10 Reverses Metronidazole-induced Cognitive Dysfunction in Rats. Journal of Advanced Pharmacy Research, 9(3), 129-136. doi: 10.21608/aprh.2025.380454.1315
Moses Bariweni; Yelaere Eradiri; Chukwubuikem Chikezie Ezeugo. "Coenzyme-Q10 Reverses Metronidazole-induced Cognitive Dysfunction in Rats". Journal of Advanced Pharmacy Research, 9, 3, 2025, 129-136. doi: 10.21608/aprh.2025.380454.1315
Bariweni, M., Eradiri, Y., Ezeugo, C. (2025). 'Coenzyme-Q10 Reverses Metronidazole-induced Cognitive Dysfunction in Rats', Journal of Advanced Pharmacy Research, 9(3), pp. 129-136. doi: 10.21608/aprh.2025.380454.1315
Bariweni, M., Eradiri, Y., Ezeugo, C. Coenzyme-Q10 Reverses Metronidazole-induced Cognitive Dysfunction in Rats. Journal of Advanced Pharmacy Research, 2025; 9(3): 129-136. doi: 10.21608/aprh.2025.380454.1315

Coenzyme-Q10 Reverses Metronidazole-induced Cognitive Dysfunction in Rats

Article 3, Volume 9, Issue 3, July 2025, Page 129-136  XML PDF (513.29 K)
Document Type: Research Article
DOI: 10.21608/aprh.2025.380454.1315
View on SCiNiTO View on SCiNiTO
Authors
Moses Bariweni email 1; Yelaere Eradiri1; Chukwubuikem Chikezie Ezeugo2
1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Niger Delta University, Wilberforce Island, Bayelsa State, Nigeria
2Department of Pharmacology & Toxicology, Faculty of Pharmacy, Igbinedion University, Okada, Edo State, Nigeria.
Abstract
Objective: Metronidazole, an essential component in surgical prophylaxis and treatment of several infections is faced with an increase in reports of neurotoxic outcomes. The search for means of resolving or abolishing the occurrence of metronidazole-induced neurotoxicity is necessary. The objective therefore is to evaluate the effects of coenzyme-Q10 on metronidazole-induced cognitive dysfunction in adult rats. Methods: Eighty adult rats were allotted to 4 groups (n=20). Group 1 was given 5 mL/kg 0.5% Tween-80®, group 2 was treated with 50 mg/kg metronidazole, group 3 was given 10 mg/kg coenzyme-Q10, group 4 was treated with metronidazole 50 mg/kg + 10 mg/kg coenzyme-Q10. All drug administrations were done daily for 28 days using the oral route. On the 28th day the rats were exposed to tests that evaluated cognitive function like the hole-board, Morris’s water maze and Y-maze test. Thereafter the animals were euthanized with halothane and the brains excised for oxidative stress tests. One-way ANOVA followed by Dunnet’s post hoc test for multiple comparison. Statistical differences were considered significant at p < 0.05. Results: Metronidazole distorted memory acquisition and learning, and decreased reference memory index (RMI) on the hole board, prolonged the time to find the escape platform in the Moris water maze, reduced percentage alternation and spatial recognition memory in the Y-maze (p < 0.01). Co-administration of coenzyme-Q10 with metronidazole reversed all the cognitive deficits induced by metronidazole in the various tests. Coenzyme-Q10 also reversed metronidazole-induced oxidative stress by increasing superoxide dismutase activity and reducing lipid peroxidation. Conclusion: In conclusion, we suggest that oxidative stress is a contributing factor to metronidazole-induced cognitive dysfunction and coenzyme-Q10 improves cognitive function, hence, could be explored to alleviate the occurrence of metronidazole-induced neurotoxicity.
Keywords
Neurotoxicity; Memory and learning; metronidazole; cognitive dysfunction; oxidative stress
Main Subjects
Section D: Clinical Pharmacy & Pharmacology
Statistics
Article View: 106
PDF Download: 34
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.